Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

After hours: March 10 at 7:59:36 PM EDT Loading Chart for ABBV ...

After hours: March 7 at 7:08:47 PM EST Loading Chart for AFMD ...

My residency director, David Carey, used to say ironically, “If you step back and take a careful look, you’ll see there’s a whole patient behind that eyeball.” ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Pulling down the lower lid, more than once I have been surprised to find a salmon-pink mass that turned out to be lymphoma. How many of us have not diagnosed a pituitary adenoma based on a visual ...

The first and only FDA-approved treatment for both adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable ...

Ocular adnexal tumors are relatively rare but require unique diagnostic and treatment considerations given the functional importance of the eye and periocular structures and their unique ...

After hours: March 7 at 7:52:08 p.m. EST Loading Chart for ABBV ...